Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05776823 · ClinicalTrials.gov registry record · NA
Pharmacist-Led Interventions to Increase Access to Medications for Opioid Use Disorders (PLI-MOUD)
A NA study of Opioid Use Disorder and Overdose, sponsored by University of Arkansas.
- Active
- Registry status
- NA
- Development phase
- 267
- Enrollment target
- 1
- Study location
NCT05776823: Active NA study of Opioid Use Disorder and Overdose, sponsored by University of Arkansas.
NCT05776823 is a NA study of Opioid Use Disorder and Overdose that is active but no longer recruiting, run by University of Arkansas. The registered enrollment target is 267 participants, below the 4,655-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05776823, a NA study of Opioid Use Disorder and Overdose, is active but no longer recruiting, sponsored by University of Arkansas.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 267 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to investigate the impact of a pharmacist-led intervention to expand access to medications for opioid use disorder (MOUD) on racial/ethnic differences in opioid-related overdose among individuals diagnosed with opioid use disorder (OUD) currently incarcerated in a carceral setting. In this study, participants will be screened for opioid use, trained to administer Narcan nasal spray, receive motivational counseling and referral to treatment post-release from a carceral setting (a Re-Entry program) into the community.
Primary Outcome
Participants' knowledge about opioid overdose and confidence to recognize and respond to opioid overdose situations as a function of the trainer. Participants will complete a brief validated survey, the adapted Perceived Competence Scale. The questions on the survey are rated on a 7-point scale and participants indicate how true four statements are about their ability to recognize and respond to overdoses: the scale, 1 (not at all true) to 7 (very true).
Conditions Studied
Interventions
- BEHAVIORAL Pharmacist Narcan Training
- BEHAVIORAL BIRT
- BEHAVIORAL SMC
- BEHAVIORAL Substance Use Counselor Narcan Training
Study Locations (1)
Arkansas
- Pulaski County Regional Detention Center - Little Rock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 267 participants |
| Start Date | 2023-05-05 |
| Est. Completion | 2026-03-17 |
| Phase | NA |
What the registry record for NCT05776823 still lists
NCT05776823 is an interventional study that assigns participants to a tested intervention. The registered 267 participants enrollment target is mid-sized for trials with a published cap, below the 4,655-participant average among 257 other Opioid Use Disorder trials with a reported enrollment target (94% lower).
The record links to 2 conditions, with Opioid Use Disorder appearing as the primary indexed condition, and to 4 interventions - of which Pharmacist Narcan Training is the first listed.
NCT05776823 reports a single indexed study location in Arkansas.
Frequently Asked Questions
What is clinical trial NCT05776823 about?
NCT05776823 is a clinical study titled "Pharmacist-Led Interventions to Increase Access to Medications for Opioid Use Disorders (PLI-MOUD)". The purpose of this study is to investigate the impact of a pharmacist-led intervention to expand access to medications for opioid use disorder (MOUD) on racial/ethnic differences in opioid-related overdose among individuals diagnosed with opioid use disorder (OUD) currently incarcerated in a carcer...
What is the current status of trial NCT05776823?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 267 participants. The study started on 2023-05-05. Estimated completion is 2026-03-17.
What conditions does trial NCT05776823 study?
This clinical trial studies the following conditions: Opioid Use Disorder, Overdose.
What interventions are being tested in trial NCT05776823?
The interventions under investigation include: Pharmacist Narcan Training (BEHAVIORAL), BIRT (BEHAVIORAL), SMC (BEHAVIORAL), Substance Use Counselor Narcan Training (BEHAVIORAL).
Who is sponsoring clinical trial NCT05776823?
This trial is sponsored by University of Arkansas, which has 318 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05776823 being conducted?
This trial has 1 study location across Arkansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Opioid Use Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05776823's enrollment target sits among peer trials
267 66th of 257 higher than 192 of 257 other Opioid Use Disorder trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Opioid Use Disorder trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Sustaining Recovery for People on Opioid Agonist Treatment With Conversational Agents
RECRUITING · NA
-
Development of an mHealth Behavioral Sleep Medicine Intervention for Use During Medication Assisted Treatment for MOUD
RECRUITING · NA
-
Systems Analysis and Improvement to Optimize Opioid Use Disorder Care Quality and Continuity for Patients Exiting Jail
RECRUITING · NA
-
Focused Ultrasound for the Complex Patient
RECRUITING · NA
-
Community-based Education, Navigation, and Support Intervention for Military Veterans
RECRUITING · NA
-
Using Facebook to Support Opioid Recovery Among American Indian Women
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04997109 · 267 participants · NA
Telemedicine in Early Childhood Constraint Therapy in Cerebral Palsy
- NCT05355701 · 267 participants · Phase 1
A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
- NCT06203509 · 267 participants · NA
Improving Care Transitions for Medicaid Insured Individuals With Co-occurring Serious Mental Illness
- NCT05000632 · 268 participants · NA
Smoke Free SafeCare: Establishing a Smoke Free Home in CPS-involved Families
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI